These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4704120)

  • 1. The conversion of the pyrrolizidine alkaloid retrorsine to pyrrolic derivatives in vivo and in vitro and its acute toxicity to various animal species.
    White IN; Mattocks AR; Butler WH
    Chem Biol Interact; 1973 Apr; 6(4):207-18. PubMed ID: 4704120
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxic effects and pyrrolic metabolites in the liver of young rats given the pyrrolizidine alkaloid retrorsine.
    Mattocks AR; White IN
    Chem Biol Interact; 1973 May; 6(5):297-306. PubMed ID: 4708048
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute hepatotoxicity and pyrrolic metabolites in rats dosed with pyrrolizidine alkaloids.
    Mattocks AR
    Chem Biol Interact; 1972 Sep; 5(4):227-42. PubMed ID: 5075756
    [No Abstract]   [Full Text] [Related]  

  • 4. Some factors affecting the conversion of pyrrolizidine alkaloids to N-oxides and to pyrrolic derivatives in vitro.
    White IN; Mattocks AR
    Xenobiotica; 1971; 1(4):503-5. PubMed ID: 4277657
    [No Abstract]   [Full Text] [Related]  

  • 5. The comparative metabolism of the four pyrrolizidine alkaloids, seneciphylline, retrorsine, monocrotaline, and trichodesmine in the isolated, perfused rat liver.
    Yan CC; Cooper RA; Huxtable RJ
    Toxicol Appl Pharmacol; 1995 Aug; 133(2):277-84. PubMed ID: 7645024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species difference in the urinary excretion of isatinecic acid from the pyrrolizidine alkaloid retrorsine.
    Chu PS; Segall HJ
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1991; 100(3):683-6. PubMed ID: 1687569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between in vitro metabolism of pyrrolizidine alkaloids and extrahepatic toxicity in vivo.
    Huxtable RJ; Wild SL
    Proc West Pharmacol Soc; 1994; 37():109-11. PubMed ID: 7984636
    [No Abstract]   [Full Text] [Related]  

  • 8. Species differences in the hepatic microsomal metabolism of the pyrrolizidine alkaloid senecionine.
    Winter CK; Segall HJ; Jones AD
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1988; 90(2):429-33. PubMed ID: 2903002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of sulphur-conjugated pyrrolic metabolites in blood and fresh or fixed liver tissue from rats given a variety of toxic pyrrolizidine alkaloids.
    Mattocks AR; Jukes R
    Toxicol Lett; 1992 Oct; 63(1):47-55. PubMed ID: 1412522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of steroidal and nonsteroidal microsomal enzyme inducers on the hepatotoxicity of pyrrolizidine alkaloids in rats.
    Tuchweber B; Kovacs K; Jago MV; Beaulieu T
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):459-80. PubMed ID: 4818386
    [No Abstract]   [Full Text] [Related]  

  • 11. The toxic effects in rats of some synthanecine carbamate and phosphate esters analogous to hepatotoxic pyrrolizidine alkaloids.
    Driver HE; Mattocks AR
    Chem Biol Interact; 1984 Sep; 51(2):201-18. PubMed ID: 6467455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excretion of pyrrolic metabolites in the bile of rats given the pyrrolizidine alkaloid retrorsine or the bis-N-ethylcarbamate of synthanecine A.
    White IN
    Chem Biol Interact; 1977 Feb; 16(2):169-80. PubMed ID: 849622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species differences in the hepatic microsomal enzyme metabolism of the pyrrolizidine alkaloids.
    Huan JY; Miranda CL; Buhler DR; Cheeke PR
    Toxicol Lett; 1998 Oct; 99(2):127-37. PubMed ID: 9817084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsomal formation of a pyrrolic alcohol glutathione conjugate of clivorine. Firm evidence for the formation of a pyrrolic metabolite of an otonecine-type pyrrolizidine alkaloid.
    Lin G; Cui YY; Hawes EM
    Drug Metab Dispos; 1998 Feb; 26(2):181-4. PubMed ID: 9456306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatotoxic effects due to pyrrolizidine alkaloid N-oxides.
    Mattocks AR
    Xenobiotica; 1971; 1(4):563-5. PubMed ID: 4950811
    [No Abstract]   [Full Text] [Related]  

  • 16. Species differences in the in vitro metabolic activation of the hepatotoxic pyrrolizidine alkaloid clivorine.
    Lin G; Cui YY; Liu XQ; Wang ZT
    Chem Res Toxicol; 2002 Nov; 15(11):1421-8. PubMed ID: 12437333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrrolic and N-oxide metabolites formed from pyrrolizidine alkaloids by hepatic microsomes in vitro: relevance to in vivo hepatotoxicity.
    Mattocks AR; Bird I
    Chem Biol Interact; 1983 Feb; 43(2):209-22. PubMed ID: 6825198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing pyrrolizidine (Senecio) alkaloid metabolism: species, liver sulfhydryls and rumen fermentation.
    Shull LR; Buckmaster GW; Cheeke PR
    J Anim Sci; 1976 Dec; 43(6):1247-53. PubMed ID: 1002625
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative study on the hepatic toxicity and metabolism of Crotalaria assamica and Eupatorium species.
    Chan MY; Zhao XL; Ogle CW
    Am J Chin Med; 1989; 17(3-4):165-70. PubMed ID: 2517380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrrolic metabolites from non-toxic pyrrolizidine alkaloids.
    Mattocks AR; White IN
    Nat New Biol; 1971 May; 231(21):114-5. PubMed ID: 5281186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.